Treatment of toxoplasmosis: Current options and future perspectives

N. Konstantinovic (1) , H. Guegan (2, 3) , T. Stäjner (1) , S. Belaz (2, 3) , F. Robert-Gangneux (2)

1 University of Belgrade [Belgrade]
2 Irset - Institut de recherche en santé, environnement et travail
3 EHESP - École des Hautes Études en Santé Publique [EHESP]

Toxoplasmosis is a worldwide parasitic disease infecting about one third of humans, with possible severe outcomes in neonates and immunocompromised patients. Despite continuous and successful efforts to improve diagnosis, therapeutic schemes have barely evolved since many years. This article aims at reviewing the main clinical trials and current treatment practices, and at addressing future perspectives in the light of ongoing researches.

Domains: Life Sciences [q-bio]; Human health and pathology; Infectious diseases; Life Sciences [q-bio]; Pharmaceutical sciences; Pharmacology

N. Konstantinovic, H. Guegan, T. Stäjner, S. Belaz, F. Robert-Gangneux. Treatment of toxoplasmosis: Current options and future perspectives. Food and Waterborne Parasitology, 2019, 15, pp.e00036. ⟨10.1016/j.fawpar.2019.e00036⟩. ⟨hal-02161208⟩